ALS drug study pulled before it even started
Knowledge-focused
Terminated
This study was designed to test an experimental drug called IC14 in people with rapidly progressing ALS. Researchers planned to use special brain scans and blood/urine tests to see if the drug could reduce signs of brain inflammation linked to the disease. However, the study was …
Phase: PHASE2 • Sponsor: Implicit Bioscience • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC